Targeting IL-6 in the Treatment of Uveitic Macular Edema
-
By
-
Rahul Khurana, MD
-
Michael A. Singer, MD
-
January 1, 2026
-
5 min
By
Rahul Khurana, MD
Michael A. Singer, MD
January 1, 2026
by Rahul Khurana, MD, Michael A. Singer, MD
January 1, 2026
Dr. David Chin Yee describes the benefits of delivering XIPERE directly into the suprachoroidal space
July 20, 2026
A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks
by Kerri Miller
March 31, 2026
A large cohort study suggests uveitis risk is lower in patients taking GLP-1 receptor agonists, compared to other antihyperglycemic drugs.
September 1, 2025